The Microbiome & Genomics Revolution:
Personalising Medicine for Health and Longevity
December 11, 2024
Palace Downtown, Dubai, UAE
Join the Microbiome & Genomics Revolution
Step into the future of healthcare at ‘The Microbiome and Genomics Revolution’, hosted by CE-Ventures. This transformative symposium brings together top scientists, investors, entrepreneurs, and healthcare leaders to explore cutting-edge breakthroughs shaping personalized health
solutions.
WHY ATTEND
Discover Innovation
Delve into the microbiome’s
impact on aging, immunity,
and chronic disease
management.
AI Meets Healthcare
Learn how AI-driven
precision medicine is
redefining wellness and
longevity.
Shape the Future
Participate in critical
discussions on making health
innovations accessible for all
a focus on overcoming barriers.
Networking Oppurtunities
Connect with visionaries
driving the next wave of
healthcare advancements
on a global scale.
As the corporate venture capital arm of Crescent Enterprises, CE-Ventures invests in transformative technologies worldwide. Our microbiome research commitment is exemplified by strategic investments in Exeliom Biosciences and Freya Biosciences, alongside collaborations with leading U.S. research institutes.
AGENDA
08:30 – 09:15
Registration and Breakfast
09:15 – 09:30
Welcome Address
Dr. Ramadan Ibrahim AlBlooshi
Advisor & Acting Director of Public Health Protection Dept,
Dubai Health Authority
09:30 – 09:45
Keynote Speech
Microbiome: The Untapped Frontier of Health and Wellness
An overview of the microbiome’s transformative potential and role in personalised health and wellness. A focus on how microbiome-based therapies can offer groundbreaking opportunities for disease prevention, longevity, and immune health.
Dr. Rob Knight
Founding Director of the Center for Microbiome Innovation,
University of California, San Diego
09:45 – 10:30
Panel Discussion
Microbiome and Longevity: Can Gut Health Extend Life?
The emerging connection between the gut microbiome and ageing is becoming apparent. Can the gut microbiome extend health spans rather than just life spans? How personalised interventions might slow down or reverse aspects of the ageing process?
Dr. Richard Siow
Director of Ageing Research,
King’s College London
Dr. Enej Kuscer
Co-founder and CEO,
NU
Dr. Richard Marshall, CBE
Chief Executive Officer,
Juvenescence
Prof. Denise Kelly
Investment Advisor,
Seventure Partners
Prof. Nicholas Arpaia (Moderator)
Associate Professor of Microbiology and Immunology,
Columbia University
10:30 – 10:50
Fireside Chat
The Ethics of Longevity: Who Gets to Live Longer and Healthier?
Understanding the potential socio-economic divide in access to longevity and anti-ageing therapies is key for equitable access. How can technology help in scaling therapies to broader populations?
Dr. Asma Al Mannaei
Executive Director of the Research and Innovation Centre,
Department of Health – Abu Dhabi
Louise Tabbiner (Moderator)
Senior Advisor,
Milken Institute
10:50 – 11:30
Coffee Break
11:30 – 12:15
Panel Discussion
Data-Driven Health: The Intersection of Genomics, Microbiome, and AI in Personalised Medicine
The convergence of genomics, microbiome data, and artificial intelligence to accelerate the emergence of personalised treatments. How AI is transforming the analysis of data, shaping precision health, and enabling tailored microbiome interventions?
Dr. Nik Sharma
Co-founder and CEO,
BioCortex
Dr. Pranab Gyawali
Consultant Gastroenterologist,
Mubadala Health Dubai
Dr. Caleb Bell
Founding President and Executive Director,
Corundum Convergence Institute
Dr. Ghida Harfouche
Partner,
TVM Capital Healthcare
Aaron Weaver (Moderator)
Chief Strategy Officer,
Centenara Labs
12:15 – 12:25
Presentation
The Microbiome and Women’s Health
How the microbiome is driving a paradigm shift in women’s reproductive health.
Dr. Colleen Acosta
Co-Founder, CEO, Board Member,
Freya Biosciences
12:25 – 13:05
Panel Discussion
Microbiome and Chronic Disease Management in the Middle East
The MENA region is witnessing a rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases. How can we address the root causes of such diseases and implement strategies and solutions that focus not only on treatment, but more importantly, on prevention?
Dr. Aashish Jha
Global Network Assistant Professor of Biology,
New York University Abu Dhabi
Dr. James McIlroy
CEO,
EnteroBiotix
Dr. Pauline Ogrodzki
Co-founder & Consultant,
Future Prescriptions
Dr. Richard Jenkins
Chief Medical Officer, Senior Executive Advisor Health Industries,
PwC
Dr. Mussaad Al-Razouki (Moderator)
Operating Partner,
Deerfield Management
13:05 – 13:15
Closing Remarks
13:15 – 14:30
Networking Lunch
SPEAKERS
Co-Founder, CEO, Board Member
Freya Biosciences
Advisor & Acting Director of Public Health Protection Dept
Dubai Health Authority
Executive Director of the Research and Innovation Centre
Department of Health – Abu Dhabi
Operating Partner
Deerfield Management
Associate Professor of Microbiology and Immunology
Columbia University
Founding President and Executive Director
Corundum Convergence Institute
Consultant Gastroenterologist
Mubadala Health Dubai
Partner
TVM Capital Healthcare
Chief Medical Officer
Senior Executive Advisor Health Industries
PwC
Global Network Assistant Professor of Biology
New York University Abu Dhabi
Investment Advisor
Seventure Partners
Founding Director of the Center for Microbiome Innovation
University of California, San Diego
Co-founder and CEO
NU
Chief Executive Officer
Juvenescence
CEO
EnteroBiotix
Co-founder & Consultant
Future Prescriptions
Co-founder and CEO
BioCortex
Director of Ageing Research
King’s College London
Senior Advisor
Milken Institute
Chief Strategy Officer
Centenara Labs